Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);用药计划表(Drug Administration Schedule);女(雌)性(Female);氟尿嘧啶(Fluorouracil);随访研究(Follow-Up Studies);人类(Humans);吲唑类(Indazoles);中年人(Middle Aged);前瞻性研究(Prospective Studies);缓解诱导(Remission Induction);时间因素(Time Factors)
PMID
2031201
发布时间
2018-05-24
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文